Among the biomarkers analyzed, serum levels of cartilage formation marker CS846 epitope and cartilage destruction marker AGC were higher in RA women before anti-TNF-α therapy than in healthy subjects (both p < 0.001; Figure 2a,b). This evidence concerns the gene TNF and rheumatoid arthritis.